BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors

  July 9, 2024

   · 

  3 min read
• Drug Development

  Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease

  July 9, 2024

   · 

  5 min read
• News

  Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study

  July 9, 2024

   · 

  7 min read
• News

  Cordis receives FDA approval for MYNX CONTROL™ VENOUS Vascular Closure Device

  July 9, 2024

   · 

  2 min read
• Drug Development

  ESSA Pharma to Present at the JonesHealthcare Seaside Summit

  July 9, 2024

   · 

  1 min read
• Drug Development

  Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference

  July 9, 2024

   · 

  1 min read
• Drug Development

  Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

  July 9, 2024

   · 

  3 min read
• News

  Gain Therapeutics Announces the Completion of Dosing of the Phase 1 Study of GT-02287

  July 9, 2024

   · 

  6 min read
• News

  Kymera Therapeutics to Present in Fireside Chat at the UBS Virtual Targeted Protein Degradation Day

  July 9, 2024

   · 

  1 min read
• News

  Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101

  July 9, 2024

   · 

  3 min read